• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[良性前列腺增生管理指南的国际比较:使用经过验证的通用工具]

[International comparison of guidelines for the management of benign prostatic hyperplasia: use of a validated generic tool].

作者信息

Irani Jacques, Brown Christian, Van der Meulen Jan, Emberton Mark

机构信息

Service d'Urologie, CHU La Milétrie, Poitiers, France.

出版信息

Prog Urol. 2004 Feb;14(1):29-32.

PMID:15098748
Abstract

INTRODUCTION

Many clinical practice guidelines (CPG) have been developed over the last decade for the management of benign prostatic hyperplasia (BPH) and associated lower urinary tract disorders. The purpose of this study was to analyse CPG published on the web until the end of 2001 and to compare their content and their methodology of development by using a validated evaluation tool. methodologies of development of CPG and their content using a validated tool.

RESULTS

The methodology of elaboration and presentation of CPG was insufficient in the majority of CPGs. The type and number of diagnostic examinations recommended by each CPG were very variable. A consensus concerning treatment was reached at the cost of poorly defined criteria, apart from complications of BPH.

CONCLUSION

The considerable number of men potentially eligible for management of voiding disorders related to BPH in the years to come will constitute a substantial medico-economic burden. Consensual rationalisation of this management by urologists in order to ensure practical application of the guidelines would limit expenditure without decreasing the quality of patient management. However, our study showed limited coherence between the various CPG, suggesting that rationalisation should first be applied to the method of development of CPG.

摘要

引言

在过去十年中,已经制定了许多临床实践指南(CPG)用于良性前列腺增生(BPH)及相关下尿路疾病的管理。本研究的目的是分析截至2001年底在网上发布的CPG,并使用经过验证的评估工具比较它们的内容及其制定方法。使用经过验证的工具分析CPG的制定方法及其内容。

结果

大多数CPG在制定和呈现方法上存在不足。每个CPG推荐的诊断检查的类型和数量差异很大。除了BPH的并发症外,关于治疗达成了共识,但代价是标准定义不明确。

结论

在未来几年中,大量可能适合管理与BPH相关排尿障碍的男性将构成巨大的医疗经济负担。泌尿科医生对这种管理进行共识合理化,以确保指南的实际应用,将在不降低患者管理质量的情况下限制支出。然而,我们的研究表明,各种CPG之间的一致性有限,这表明合理化应首先应用于CPG的制定方法。

相似文献

1
[International comparison of guidelines for the management of benign prostatic hyperplasia: use of a validated generic tool].[良性前列腺增生管理指南的国际比较:使用经过验证的通用工具]
Prog Urol. 2004 Feb;14(1):29-32.
2
Profile and management of patients treated for the first time for lower urinary tract symptoms/benign prostatic hyperplasia in four European countries.四个欧洲国家首次因下尿路症状/良性前列腺增生接受治疗的患者情况及管理
BJU Int. 2008 May;101(9):1111-8. doi: 10.1111/j.1464-410X.2008.07498.x. Epub 2008 Feb 15.
3
Canadian guidelines for the management of benign prostatic hyperplasia.加拿大良性前列腺增生管理指南。
Can J Urol. 2005 Jun;12(3):2677-83.
4
New diagnostic and treatment guidelines for benign prostatic hyperplasia. Potential impact in the United States.
Arch Intern Med. 1995 Mar 13;155(5):477-81.
5
Translation of benign prostatic hyperplasia guidelines into clinical practice.良性前列腺增生症指南在临床实践中的转化
Curr Opin Urol. 2008 Jan;18(1):56-60. doi: 10.1097/MOU.0b013e3282f13bbf.
6
The American Urological Association 2003 guideline on management of benign prostatic hyperplasia: a Canadian opinion.美国泌尿外科学会2003年良性前列腺增生管理指南:加拿大的观点。
Can J Urol. 2004 Apr;11(2):2186-93.
7
[Comparative evaluation of clinical practice guidelines for the treatment of schizophrenia].[精神分裂症治疗临床实践指南的比较评估]
Encephale. 2008 Jan;34(1):93-100. doi: 10.1016/j.encep.2007.07.004. Epub 2007 Oct 24.
8
A review of guidelines on benign prostatic hyperplasia and lower urinary tract symptoms: are all guidelines the same?良性前列腺增生与下尿路症状指南综述:所有指南都一样吗?
BJU Int. 2003 Dec;92(9):937-42. doi: 10.1111/j.1464-410x.2003.04529.x.
9
American Urological Association and European Association of Urology guidelines in the management of benign prostatic hypertrophy: revisited.美国泌尿外科学会和欧洲泌尿外科学会良性前列腺增生管理指南:再探讨。
Curr Opin Urol. 2012 Jan;22(1):34-9. doi: 10.1097/MOU.0b013e32834d8e87.
10
[Prevalence of benign prostatic hyperplasia in general practice and practical approach of the Tunisian general practitioner (Prevapt study)].[突尼斯全科医生在一般诊疗中良性前列腺增生的患病率及实际诊疗方法(Prevapt研究)]
Tunis Med. 2007 Aug;85(8):619-24.

引用本文的文献

1
Sociodemographic Factors Related to Lower Urinary Tract Symptoms in Men: A Korean Community Health Survey.男性下尿路症状相关的社会人口学因素:一项韩国社区健康调查。
Int Neurourol J. 2017 Jun;21(2):143-151. doi: 10.5213/inj.1732760.380. Epub 2017 Jun 21.
2
Korean urologist's view of practice patterns in diagnosis and management of benign prostatic hyperplasia: a nationwide survey.韩国泌尿科医生对良性前列腺增生症诊断和治疗模式的看法:一项全国性调查。
Yonsei Med J. 2010 Mar;51(2):248-52. doi: 10.3349/ymj.2010.51.2.248. Epub 2010 Feb 12.